Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 1 client • 4 examiners • 2 art units • 0 of 6 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Wideband IP Office works in Biotechnology & Pharmaceuticals and reports 146 career applications. Six pending office actions are shown, indicating an active but defined unresolved workload. The resolved allowance rate is 67.39%, providing an outcome measure for the resolved applications in the profile.
The average is 2.77 office actions per allowance, indicating that matters reaching allowance generally involve multiple examination responses. The allowance rate and action average describe different practitioner concerns: the first addresses recorded outcomes, while the second addresses the process required to reach allowance. The application volume is limited in the context of the profile, so each metric should be read with attention to the available base.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| Multi-statute (no §101) | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHEN, CATHERYNE | 2 | 37.5% | +17.9% |
| SPAINE, ROBERT FRANKLIN | 2 | 75.0% | +0.0% |
| TRAN, SUSAN T | 1 | 63.0% | +34.8% |
| MOREAU, NASHARA LOUISE | 1 | 66.7% | -80.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18395764 | METHODS FOR IMPROVING BONE QUALITY AND PROMOTING CARTILAGE DIFFERENTIATION BY CHRYSOPHYLLUM CAINITO EXTRACT AND MANUFACTURING METHOD THEREOF | CHEN, CATHERYNE | 14d |
| 18855329 | USE OF PRUNUS LANNESIANA EXTRACT FOR IMPROVING SKIN CONDITION AND BASAL METABOLIC RATE | CHEN, CATHERYNE | — |
| 18426360 | METHODS FOR ENHANCING SKIN RESISTANCE, IMPROVING SKIN SMOOTHNESS, OR IMPROVING SKIN BRIGHTNESS BY USING AMPELOPSIS GROSSEDENTATA LEAF EXTRACT | TRAN, SUSAN T | — |
| 18528783 | METHODS FOR RESISTING SKIN AGING BY USING KIWIBERRY EXTRACT | SPAINE, ROBERT FRANKLIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18395764 | METHODS FOR IMPROVING BONE QUALITY AND PROMOTING CARTILAGE DIFFERENTIATION BY CHRYSOPHYLLUM CAINITO EXTRACT AND MANUFACTURING METHOD THEREOF | CHEN, CATHERYNE | 14d |
| 18855329 | USE OF PRUNUS LANNESIANA EXTRACT FOR IMPROVING SKIN CONDITION AND BASAL METABOLIC RATE | CHEN, CATHERYNE | — |
| 18426360 | METHODS FOR ENHANCING SKIN RESISTANCE, IMPROVING SKIN SMOOTHNESS, OR IMPROVING SKIN BRIGHTNESS BY USING AMPELOPSIS GROSSEDENTATA LEAF EXTRACT | TRAN, SUSAN T | — |
| Client (Assignee) | Pending OAs |
|---|---|
| TCI CO., LTD. | 6 |
| Art Unit | Apps |
|---|---|
| 1655 | 5 |
| 1615 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18855329 | USE OF PRUNUS LANNESIANA EXTRACT FOR IMPROVING SKIN CONDITION AND BASAL METABOLIC RATE | Tci Co., Ltd. | CHEN, CATHERYNE | 1655 | §102§112 | Non-Final OA | — | Pending | Oct 09, 2024 |
| 18426360 | METHODS FOR ENHANCING SKIN RESISTANCE, IMPROVING SKIN SMOOTHNESS, OR IMPROVING SKIN BRIGHTNESS BY USING AMPELOPSIS GROSSEDENTATA LEAF EXTRACT | Tci Co., Ltd. | TRAN, SUSAN T | 1615 | §102§103 | Final Rejection | — | Pending | Jan 30, 2024 |
| 18409817 | METHODS FOR IMPROVING SLEEP QUALITY, INCREASING MITOCHONDRIAL EXPRESSION, PROMOTING CELL REPAIRING, OR FIRMING SKIN BY USING SPARASSIA CRISPA EXTRACT | Tci Co., Ltd. | SPAINE, ROBERT FRANKLIN | 1655 | §103 | Final Rejection | 13d | Pending | Jan 11, 2024 |
| 18395764 | METHODS FOR IMPROVING BONE QUALITY AND PROMOTING CARTILAGE DIFFERENTIATION BY CHRYSOPHYLLUM CAINITO EXTRACT AND MANUFACTURING METHOD THEREOF | Tci Co., Ltd. | CHEN, CATHERYNE | 1655 | §103§112 | Final Rejection | 14d | Pending | Dec 26, 2023 |
| 18528783 | METHODS FOR RESISTING SKIN AGING BY USING KIWIBERRY EXTRACT | Tci Co., Ltd. | SPAINE, ROBERT FRANKLIN | 1655 | §102§103§112 | Non-Final OA | — | Pending | Dec 05, 2023 |
| 18518451 | METHOD FOR REGULATING IMMUNITY BY USING BLACK HULLESS BARLEY EXTRACT | Tci Co., Ltd. | MOREAU, NASHARA LOUISE | 1655 | §103 | Non-Final OA | 75d | Pending | Nov 23, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial67.4% of resolved applications prosecuted by Wideband Ip Office were allowed, across 146 applications in USPTO records.
2.77 office actions per allowed application on average.
6 pending office actions as of October 2026, for 1 client, before 4 examiners in 2 art units.
